1635.4000 19.80 (1.23%)
NSE Jun 11, 2025 15:53 PM
Volume: 996.3K
 

1635.40
1.23%
ICICI Securities Limited
Traction in Ryaltris across EU and RoW markets drove a robust 22.5% YoY growth in Glenmark’s revenue in Q1FY24. Divestment of Razel and other derma brands took a toll on India growth (up 2.8% YoY).
Glenmark Pharmaceuticals Ltd. has gained 16.96% in the last 1 Month
More from Glenmark Pharmaceuticals Ltd.
Recommended